Johnson & Johnson (JNJ) Tops Q3 EPS by 22c, Raises FY Guidance
(Updated - October 13, 2020 6:42 AM EDT)
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.20, $0.22 better than the analyst estimate of $1.98. Revenue for the quarter came in at $21.1 billion versus the consensus estimate of $20.2 billion.
GUIDANCE:
Johnson & Johnson sees FY2020 EPS of $7.95-$8.05, versus the consensus of $7.89. Johnson & Johnson sees FY2020 revenue of $81.2-82 billion, versus the consensus of $80.75 billion.
The estimated impact of the COVID-19 pandemic is included in the guidance below.
October 2020 | July 2020 | |
($ in Billions, except EPS) | ||
Adjusted Operational Sales1,2 Change vs. Prior Year | 0.5% – 1.5% | (0.8%) – 1.0% |
Operational Sales2 Change vs. Prior Year | $82.0 to $82.8 0.0% – 1.0% | $81.0 to $82.5 (1.3%) – 0.5% |
Estimated Reported Sales3 Change vs. Prior Year | $81.2 to $82.0 (1.0%) – 0.0% | $79.9 to $81.4 (2.6%) – (0.8%) |
Adjusted Operational EPS (Diluted)2,4 Change vs. Prior Year | $7.95 to $8.05 (8.4%) - (7.3%) | $7.85 to $8.05 (9.6%) - (7.3%) |
Adjusted EPS (Diluted)3,4 Change vs. Prior Year | $7.95 to $8.05 (8.4%) – (7.3%) | $7.75 to $7.95 (10.7%) – (8.4%) |
1 Non-GAAP financial measure; excludes the net impact of acquisitions and divestitures |
2 Non-GAAP financial measure; excludes the impact of translational currency |
3 Calculated using Euro Average Rate: October 2020 = $1.14 Euro Average Rate: July 2020 = $1.12 (Illustrative purposes only) |
4 Non-GAAP financial measure; excludes intangible amortization expense and special items |
Other modeling considerations will be provided on the webcast.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.